Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I-III Colorectal Cancer.

Tong YuJinglue SongHui ZhouTingyu WuZhonglin LiangPeng DuChen-Ying LiuGuanghui WangLong CuiYun Liu

Published in: Cancer management and research (2021)

Our study identifies TEAD4-SIX1-CDH1 form a novel signaling axis, which contributes to CRC progression, and its aberrant expression and activation predicts poor prognostic for CRC patients in stage I-III.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
poor prognosis
prognostic factors
peritoneal dialysis
cell proliferation
genome wide
transcription factor
gene expression
dna methylation
patient reported outcomes